Weijing Sun
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 62
- Colorectal Cancer Treatments and Studies 24
- Pancreatic and Hepatic Oncology Research 14
- Cancer Immunotherapy and Biomarkers 7
- Colorectal Cancer Surgical Treatments 6
- Hepatology 15
- Hepatocellular Carcinoma Treatment and Prognosis 15
- Co-authors
- Peter James O'Dwyer (22 shared papers)Ursina R. Teitelbaum (5 shared papers)Daniel G. Haller (20 shared papers)Robert H. Vonderheide (3 shared papers)Drew A. Torigian (2 shared papers)Babak Saboury (2 shared papers)Elena Gabriela Chiorean (2 shared papers)Gregory Lawrence Beatty (2 shared papers)
- Journals
- Cancer (9 papers)Journal of Hematology & Oncology (7 papers)Clinical Colorectal Cancer (5 papers)Journal of Clinical Oncology (5 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Weijing Sun
160 papers receiving 11.1k citations
Weijing Sun's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 3.6k
- Hepatology 962
- Immunology 669
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 335
Countries citing papers authored by Weijing Sun
This map shows the geographic impact of Weijing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Sun more than expected).
Fields of papers citing papers by Weijing Sun
This network shows the impact of papers produced by Weijing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Sun. The network helps show where Weijing Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Weijing Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 164 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Hit paper breakdown → | 2018 | 1485 |
| 2 | CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans Hit paper breakdown → | 2011 | 1421 |
| 3 | Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Hit paper breakdown → | 2018 | 1060 |
| 4 | Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2019 | 590 |
| 5 | 2018 | 451 | |
| 6 | 2013 | 395 | |
| 7 | 1994 | 305 | |
| 8 | 2005 | 293 | |
| 9 | Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial Hit paper breakdown → | 2018 | 293 |
| 10 | 2020 | 270 | |
| 11 | 2003 | 264 | |
| 12 | 2010 | 181 | |
| 13 | 2018 | 180 | |
| 14 | 2004 | 179 | |
| 15 | 2016 | 137 | |
| 16 | 2013 | 135 | |
| 17 | 2014 | 135 | |
| 18 | 2010 | 128 | |
| 19 | 2018 | 113 | |
| 20 | 2010 | 106 |
About Weijing Sun
Weijing Sun is a scholar working on Oncology, Hepatology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 164 papers that have together received 11.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and Esophageal Cancer Research and Treatment (6 papers). The work is most often cited by research in Oncology (3.6k citations), Hepatology (962 citations), Immunology (669 citations), Pulmonary and Respiratory Medicine (1.0k citations) and Cancer Research (335 citations). Weijing Sun has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Peter James O'Dwyer, Ursina R. Teitelbaum, Daniel G. Haller, Robert H. Vonderheide, Drew A. Torigian, Babak Saboury, Elena Gabriela Chiorean, Gregory Lawrence Beatty, Leslie L. Sharp and Richard Dale Huhn. Their work appears in journals such as Cancer, Journal of Hematology & Oncology, Clinical Colorectal Cancer, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.